| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2010 | US7790905 sodium salt of celecoxib |
| 09/07/2010 | US7790904 Substituted benzimidazole derivatives |
| 09/07/2010 | US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
| 09/07/2010 | US7790898 Substituted 3-phenylpiperidine compounds, their preparation and use |
| 09/07/2010 | US7790881 Methylene blue; nitrosation, reduction; thiosulfonic acid forming; oxidative coupling; viricides, bactericides, antiprotozoa agents, anticancer agents |
| 09/07/2010 | US7790878 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
| 09/07/2010 | US7790870 nucleic acid molecule encoding a fusion protein comprising four linked polypeptides; suitable for use in gene therapeutical treatment of patients infected with HIV |
| 09/07/2010 | US7790867 Vaccinia virus-related nucleic acids and microRNA |
| 09/07/2010 | US7790773 a cyclopentene sugar amine derivative useful as beta -galactosidase stabilizing agent |
| 09/07/2010 | US7790772 administering desmethylsertraline a monoamine reuptake inhibitor, for the treatment of brain disorders, behavioral disorders, eating disorders, disorders, sexual disorders, drug abuse and dependence, and for the prophylaxis of headaches |
| 09/07/2010 | US7790771 Chloramine-t as a wound healing agent and viricide, particularly the herpes and varicella viruses; pruritus; skin disorders; diseasesof the mucous membranes, organs and tissues; with the exception of treatment of retro-viral (HIV) diseases; dermatitis; acne; psoriasis; side effect reduction |
| 09/07/2010 | US7790770 Heterocyclic CETP inhibitors |
| 09/07/2010 | US7790769 such as 2-{3-[Bis-(2-ethyl-hexyl)-amino]-cyclohex-2-enylidene}-malononitrile, used for the protection of human hair and skin against the damaging effect of ultraviolet radiation; sunscreen agents; cosmetics |
| 09/07/2010 | US7790768 Method for increasing hair growth |
| 09/07/2010 | US7790767 Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
| 09/07/2010 | US7790766 Comprising [4-[(N,N-diethylcarbamoyl)methoxy]-3-ethoxyphenyl]acetic acid propyl ester, a water-immiscible solvent, an emulsifier, a tonicity modifier, 0.05-0.2% by weight histidine, and water,wherein pH is greater than 7 and wherein composition contains a preservative |
| 09/07/2010 | US7790765 Sodium 6-hydroxy-2,2-dimethyl-5-oxo-3,4,5,6-tetrahydro-2H-benzo(h)chromene-6-sulfonate; anticarcinogenic agents; antitumor agents; antiproliferitive agents; pharmakinetics; solubility;bioavailability; stability; reacting beta-lapachone with sodiumhydrogensulfite |
| 09/07/2010 | US7790764 Biologically active macrolides, compositions, and uses thereof |
| 09/07/2010 | US7790763 such as Rac-(2-isopropoxy-5-methanesulfonyl-phenyl)-[3-(4-trifluoromethyl-phenoxy)-pyrrolidin-1-yl]-methanone, having good glycine transporter inhibitory activity and useful for the treatment of nervous system disorders such as schizophrenia, cognitive impairment and Alzheimer's disease |
| 09/07/2010 | US7790762 A heteroaryl bonded to a phenol through a ketone and a double bond; cystic fibrosis |
| 09/07/2010 | US7790761 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole |
| 09/07/2010 | US7790760 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286 |
| 09/07/2010 | US7790759 antiinflammatory, analgesic, antiallergic, cough-preventing, liver-protecting and anti-viral properties; side effects reduction; N-[(3-p-hydroxylphenyl-isoxazol-5-yl)methyl]-glycyrrhetinamide |
| 09/07/2010 | US7790758 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide; stereoselectively epoxidising a suitable styrene; coupling with boronic acid derivatives |
| 09/07/2010 | US7790757 Administering a compound (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl-4-penten-2-amine; attention deficit disorder |
| 09/07/2010 | US7790756 useful for the modulation of kinase activity of C-Abl, c-Kit, VEGFR, PDGFR, Flt-3, c-MET, HER family, Raf kinase family and disease polymorphs thereof; hyperproliferative diseases, cancer; 1-(5-(4-(1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorophenyl)-3-(3-isopropyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)urea |
| 09/07/2010 | US7790755 Controlled release preparation |
| 09/07/2010 | US7790754 such as (2R) N-((1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide, useful in the treatment or prevention of symptoms such as pain and inflammation; analgesics and antiinflammatory agents |
| 09/07/2010 | US7790753 Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 09/07/2010 | US7790752 Indol-3-yl-carbonyl-azaspiro derivatives |
| 09/07/2010 | US7790751 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/07/2010 | US7790750 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 09/07/2010 | US7790749 Antiulcer agents; gastrointestinal disorders; anticancer agents; anemia |
| 09/07/2010 | US7790748 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 09/07/2010 | US7790747 piperidine derivatives such as 6-Chloro-N ((R)-3-{4-[(2-cyano-1-ethylamino-vinyl)-thiophen-3-ylmethyl-amino]-piperidin-1-yl}-butyl)-2,4-dimethyl-nicotinamide, used for preventing infection of target cells by a human immunodeficiency virus and in the treatment of inflammatory and autoimmune diseases |
| 09/07/2010 | US7790746 4-anilinoquinoline derivatives such as of N-(4-(2-Amino-6-Methylpyrimidin-4-Ylamino)Phenyl)-4-(Quinolin-4-Ylamino)Benzamide, effective in inhibiting the methylation of cytosine at the C-5 position, via selective inhibition of DNA methyltransferase, useful in treating cancer and bllod disorders |
| 09/07/2010 | US7790745 modulators of nuclear receptors, including liver X receptor (LXR), such as 2-tert-butyl 1-methyl 6-(3- methoxybenzyloxy)-3,4- dihydroisoquinoline-1,2(1H)- dicarboxylate, useful in the treatment of arteriosclerosis, atherosclerosis, hypercholesterolemia, hyperlipemia, hypertriglyceridemia and diabetes |
| 09/07/2010 | US7790743 Modulators of cellular adhesion |
| 09/07/2010 | US7790742 6,8-dichloro-2-methyl-4-[4N-(2-ethoxy-3,4-dioxocyclobuten-1-yl)amino]phenyl-1,2,3,4-tetrahydroisoquinoline, used as regulators of the intracellular pH environment, transport protein and carbonic anhydrase inhibitors; treatment of urogenital, respiratory system, cardiovascular and nervous system disorders |
| 09/07/2010 | US7790741 Imidazothiazoles and imidazoxazoles |
| 09/07/2010 | US7790740 administering chemokine receptor antagonist such as N-{(1S)-3-[3-endo-(5-Acetyl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-(-3-fluorophenyl)propyl}acetamide, for the treatment of viral, bacterial and protozoa infections |
| 09/07/2010 | US7790739 Tyrosine kinase inhibitors |
| 09/07/2010 | US7790738 Methods of treating and preventing AIDS using of COX-2 inhibitors |
| 09/07/2010 | US7790737 cholesterol ester transfer protein (CETP) inhibitors, such as 5-[({1-[3,5-bis(trifluoromethyl)phenyl]ethyl}{5-[2-(methylthio)ethoxy]pyrimidin-2-yl}amino)methyl]-N-(cyclopentylmethyl)-N-ethyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-amine; treatment of cardiovascular disorders and abnormal lipidemia |
| 09/07/2010 | US7790736 Dipeptidyl peptidase inhibitors |
| 09/07/2010 | US7790735 Methanocarba cycloalkyl nucleoside analogues |
| 09/07/2010 | US7790734 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; anticancer agents; skin disorders |
| 09/07/2010 | US7790733 such as 8-methoxy-4-methyl-3,4-dihydro-quinazolin-2-ylamine, serotonin receptor antagonists used for the treating schizophrenia, sexual dysfunction, obsessive compulsive, post-traumatic stress, sleep, eating, gastrointestinal and psychological disorders, as anxiolytic agents, antidepressants, analgesics |
| 09/07/2010 | US7790732 such as 5-chloro-4-methyl-3,4-dihydro-quinazolin-2-ylamine, having good activity on the serotonin receptors, used for treating sleep disorders, schizophrenia and as antidepressants or anxiolytic agents |
| 09/07/2010 | US7790731 2-Methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone; sleep, psychological, nervous system, and attention deficit disorders; drug abuse, alcoholism; antidiabetic agents, cognition activators; Alzheimer's and Parkinson's disease; histamine H3 receptor antagonists |
| 09/07/2010 | US7790730 1-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)-8-(2,3-difluorophenyl)-1H-purine, used treat or prevent viral infections such as hepatitis C virus (HCV) |
| 09/07/2010 | US7790729 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), receptor antagonists, such as N-(3-Fluoro-4-(2- (thiophen-2-yl)thieno[3,2- b]pyridin-7- yloxy)phenylcarbamothio- yl)-2-phenylacetamide, used for treating angiogenesis-mediated cell proliferative diseases or as antitumor agents |
| 09/07/2010 | US7790728 Pyrazine derivatives useful as adenosine receptor antagonists |
| 09/07/2010 | US7790727 4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methoxy-phenyl]- piperazine-1-carboxylic acid tert-butyl ester; nervous system disorders, particularly the central nervous system; obesity; cogition activators; Alzheimer's disease; drug abuse, drug dependence; schizophrenia; bioavailability; stability |
| 09/07/2010 | US7790726 chemokine receptor antagonists such as 6-Chloro-3-{2-[4-(4-chloro-3-methoxy-phenyl)-4-hydroxy-piperidin-1-yl]-2-oxo-ethyl}-3H-benzooxazol-2-one, having in vivo antiinflammatory activity |
| 09/07/2010 | US7790725 Thiazolidine derivatives and medicinal use thereof |
| 09/07/2010 | US7790724 c-fms kinase inhibitors |
| 09/07/2010 | US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes |
| 09/07/2010 | US7790722 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders |
| 09/07/2010 | US7790721 Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase |
| 09/07/2010 | US7790720 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 09/07/2010 | US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
| 09/07/2010 | US7790718 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 09/07/2010 | US7790717 administering 3-(4'-Morpholin-4-ylmethyl-biphenyl-4-ylmethyl)-1-oxa-3-aza-spiro[4.5]decan-2-one, for the treatment of schizophrenia |
| 09/07/2010 | US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics |
| 09/07/2010 | US7790715 Organic compounds |
| 09/07/2010 | US7790714 Oxadiazoanthracene compounds for the treatment of diabetes |
| 09/07/2010 | US7790713 Inhibitors of interleukin-1β converting enzyme |
| 09/07/2010 | US7790712 and Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2 inhibitors, used for preventing or treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 09/07/2010 | US7790711 Inhibitors of 11β-Hydroxysteroid Dehydrogenase |
| 09/07/2010 | US7790710 Imidazopyridine derivatives useful as iNOS inhibitors |
| 09/07/2010 | US7790709 Heterocyclic compounds, methods of making them and their use in therapy |
| 09/07/2010 | US7790708 Prodrugs of GABA analogs, compositions and uses thereof |
| 09/07/2010 | US7790707 S1P receptor modulating compounds and use thereof |
| 09/07/2010 | US7790706 Modulation of glucocorticoid metabolism by modulating the functional activity of 5-alpha reduced metabolites; use of 5 alpha-reductase inhibitors such as finasteride, G1108745, indomethacin and LY191704 |
| 09/07/2010 | US7790705 Minocycline oral dosage forms for the treatment of acne |
| 09/07/2010 | US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 09/07/2010 | US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability |
| 09/07/2010 | US7790702 Protein or hydrolyzate/phospholipid complex; used to improve lipid metabolism; functional food comprising the complex; anticholesterol agents |
| 09/07/2010 | US7790700 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 09/07/2010 | US7790699 Self-gelling alginate systems and uses thereof |
| 09/07/2010 | US7790698 2-Alkoxyadeosine or 2-alkoxy-3'-deoxyadenosine where the alkoxy contains 1-4 carbon atoms; particularly 2-methoxy-adenosine (spongosine) or salt; antiinflammatory agents; side effect reduction, particularly, cardiovascular disorders such as bradycardia and tachycardia |
| 09/07/2010 | US7790697 A matrix metalloproteinase 1 siRNA molecule comprising SEQ ID NO:1 and SEQ ID NO:2; collengenase; enzyme inhibitors; antitumor agents; anticarcinogenic agents; antimetastatic agents; antisense therapy |
| 09/07/2010 | US7790696 Cationic liposomes containing immune response generating moieties |
| 09/07/2010 | US7790694 Antisense antibacterial method and compound |
| 09/07/2010 | US7790693 Increasing insulin-stimulated glucose uptake in a cell in vitro byadministering to the cell an inhibitory RNA that decreases expressionor activity of mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4); glucose transport proteins; kinase inhibitors |
| 09/07/2010 | US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 09/07/2010 | US7790691 A first oligonucletide and a second are complimentary and hybridize with each other to a target nucleic acid for their use in modulating gene expression; hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA |
| 09/07/2010 | US7790690 Glucose sensitive regulator of insulin transcription |
| 09/07/2010 | US7790689 1,2-O-isopropylidene-3-deoxy-3-(phenyl-thiourido)-alpha-D- glucofuranoside; antinflammatory agents; asthma; autoimmune diseases; antiarthritic agents; antidiabetic agents; multiple sclerosis; transplant rejection; psoriasis; inflammatory bowel disease; ulcerative colitis; acne, anticarcinognenic |
| 09/07/2010 | US7790688 Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
| 09/07/2010 | US7790686 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 09/07/2010 | US7790681 Binding to receptor of glucagon-like peptide; congestive heart failure |
| 09/07/2010 | US7790680 Hemophilia biodrug recombinant porcine factor 8 formulation with replacement for albumin stabilizer, which may carry risk of prions; surfactant such as polysorbate, calcium chloride, sucrose, sodium chloride, trisodium citrate, and a buffer devoid of amino acids |
| 09/07/2010 | US7790678 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use |
| 09/07/2010 | US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT |
| 09/07/2010 | US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 09/07/2010 | US7790362 Prostaglandin E1 as platelet inhibitor; signal transduction; solid phase synthesis; kits |
| 09/07/2010 | US7790215 Pharmaceutically acceptable mixture of gelatin and hydrophobic polymer |
| 09/07/2010 | US7790205 administering to mammal a composition comprising a first component selected from dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, a second component selected from the group consisting of rosemary, an extract derived from rosemary |